Cc1nnc(O)c2c(NC(=O)CSc3nnc(-c4ccco4)n3C)oc(C)c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?